Anticoagulants Market Boosted by Rising AFib Cases & Demand for DOACs - Global Industry Forecast 2025 | Johnson & Johnson, Pfizer Inc., Bristol-Myers Squibb

The Global Anticoagulants Market reached US$ 38.13 billion in 2024 and is expected to reach US$ 73.91 billion by 2032, growing at a CAGR of 8.6% during the forecast period 2025-2032.

The latest Anticoagulants Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/anticoagulants-market?ophp

Anticoagulants are drugs that prevent or reduce blood clot formation, commonly used for conditions like atrial fibrillation and deep vein thrombosis. The market is experiencing significant growth driven by rising cardiovascular disease prevalence and the adoption of novel oral anticoagulants that offer improved safety and patient convenience.

Anticoagulants Market Competitors Overview:

The major global players in the anticoagulants market include Johnson & Johnson, Pfizer Inc., Bristol-Myers Squibb, DAIICHI SANKYO COMPANY, LIMITED., Boehringer Ingelheim International GmbH., Sanofi, Aspen Healthcare FZ LLC, Teva Pharmaceuticals USA, Inc.

Important Industry Updates of 2024 and 2025:

✅ In April 2024, Cadrenal Therapeutics, Inc. a biopharmaceutical company focused on developing tecarfarin, a novel oral and reversible anticoagulant, announced that the U.S. Food and Drug Administration (FDA) has granted tecarfarin Orphan Drug Designation (ODD). This designation is specifically for the prevention of thromboembolism and thrombosis in patients with implanted mechanical circulatory support devices, which include left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), biventricular assist devices, and total artificial hearts.

✅ In February 2024, Roche Holding AG launched three new coagulation tests specifically designed for the oral Factor Xa inhibitors: apixaban, edoxaban, and rivaroxaban. These tests are now available in countries that accept the CE mark, reflecting Roche's commitment to meeting the increasing demand for effective anticoagulation monitoring.

Anticoagulants Market Segments Overview:

∎ By Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low-Molecular-Weight Heparin (LMWH), Vitamin K Antagonists, Others)
∎ By Route of Administration (Oral Anticoagulants, Injectable Anticoagulants)
∎ By Application(Atrial Fibrillation & Heart Attack, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Others)
∎ By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/anticoagulants-market?ophp

Methodology and Scope:

This Anticoagulants Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Anticoagulants Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=anticoagulants-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Anticoagulants market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Anticoagulants market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.